2021
DOI: 10.1002/cmdc.202000992
|View full text |Cite
|
Sign up to set email alerts
|

New Paradigm in NKT Cell Antigens: MCS‐0208 (2‐(Hydroxymethyl)phenylthio‐phytoceramide) – an Aryl‐Phytoceramide Compound with a Single Hydroxyl Group Stimulates NKT Cells

Abstract: Natural Killer T (NKT) cells play an important role in the immune response and can be activated by glycolipids presented by CD1d protein. We present MCS‐0208, an unprecedented arylthioether‐phytoceramide able to induce potent invariant NKT (iNKT) cell activation, notably when tested in human iNKT cells. This arylsphingolipid analog has a simple phenyl group containing a single hydroxyl substituent as a surrogate of the sugar ring. The phenylthioether structure contrasts with α‐galactosylceramide (1), the proto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…We expect that this, combined with immunological investigations proving their utility and advances in chemical synthesis, will underpin future studies that can pave the way for clinical use of compounds exploiting this biological mechanism. Here, we have described studies centered on αGalCer, however there is a future beyond galactose, as evident by studies of e. g. βManCer [167] and even non‐glycosylated lipids [168] …”
Section: Conclusion and Future Perspectivementioning
confidence: 99%
See 1 more Smart Citation
“…We expect that this, combined with immunological investigations proving their utility and advances in chemical synthesis, will underpin future studies that can pave the way for clinical use of compounds exploiting this biological mechanism. Here, we have described studies centered on αGalCer, however there is a future beyond galactose, as evident by studies of e. g. βManCer [167] and even non‐glycosylated lipids [168] …”
Section: Conclusion and Future Perspectivementioning
confidence: 99%
“…Here, we have described studies centered on αGalCer, however there is a future beyond galactose, as evident by studies of e. g. βManCer [167] and even non-glycosylated lipids. [168]…”
Section: Conclusion and Future Perspectivementioning
confidence: 99%